Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Barinthus Biotherapeutics Plc ADR (BRNS)

Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Barinthus Biotherapeutics Plc ADR UNIT 6-10 ZEUS BUILDING RUTHERFORD AVENUE DIDCOT X0 OX11 0DF GBR

www.barinthusbio.com P: 44-18-6581-8808

Description:

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus Biotherapeutics plc, formerly known as Vaccitech plc, is based in OXFORD, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 54,646
Enterprise Value, $K -87,444
Shares Outstanding, K 39,033
Annual Sales, $ 800 K
Annual Net Income, $ -73,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,490 K
EBIT, $ -79,350 K
EBITDA, $ -73,920 K
60-Month Beta -0.52
% of Insider Shareholders 8.00%
% of Institutional Shareholders 25.20%
Float, K 35,910
% Float 92.00%
Short Volume Ratio 0.18

Growth:

1-Year Return -36.36%
3-Year Return -90.46%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 05/13/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -1.84
EPS Growth vs. Prev Qtr 11.11%
EPS Growth vs. Prev Year 16.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BRNS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.61%
Return-on-Assets % -31.75%
Profit Margin % -9,168.75%
Debt/Equity 0.00
Price/Sales 70.04
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 4.42
Interest Coverage -2,549.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar